Evidence map›Paper›PMID 39891455›Full record

ArticleArchives of Iranian medicine2024

Radiological Findings for Distinguishing Between Xanthogranulomatous Cholecystitis and Gallbladder Cancer.

Ahmet Bozer, Nagihan Durgun

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmet BozerDepartment of Radiology, Izmir City Hospital, Izmir, Turkey.ORCID 0000-0002-0467-741X
Nagihan DurgunDepartment of Radiology, Izmir City Hospital, Izmir, Turkey.ORCID 0009-0009-6159-6569

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXanthogranulomatous cholecystitis (XGC) is a rare, chronic gallbladder inflammation often mistaken for gallbladder cancer (GBC) on imaging. Accurate differentiation is vital for appropriate treatment. This study aims to enhance computed tomography (CT) scan diagnostic accuracy for distinguishing XGC from GBC.

methodsThis retrospective study included patients diagnosed with XGC and GBC between 2014 and 2023. CT images of 70 patients (16 GBC, 54 XGC) were reviewed. Radiologists assessed CT parameters: gallbladder wall thickening, intramural hypoattenuating nodules, enhancement characteristics, mucosal line continuity, pericholecystic fat stranding, presence of stones, bile duct dilatation, hepatic invasion, invasion to adjacent structures, and lymph node size.

resultsAmong 70 patients, there were 38 males (54%) and 32 females (46%), with a median age of 62 years. GBC patients were significantly older (median age 72 years) compared to XGC patients (60 years) (

conclusionCT imaging can effectively differentiate XGC from GBC, and larger studies can further improve diagnostic accuracy.

Indexed as

CholecystitisGallbladderGallbladder NeoplasmsGranulomaTomography, X-Ray ComputedXanthomatosisAdultAgedAged, 80 and overDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityComputed tomographyDifferential diagnosisGallbladder cancerRadiologyXanthogranulomatous cholecystitis

Identifiers

PMID39891455
PMCPMC11786208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.